CIB2 mediates acquired gefitinib resistance by inducing ZEB1 expression and epithelial-mesenchymal transition
Aging · 2024
DOI: 10.18632/aging.206086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Feng-Mei Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Science, Zhengzhou University, Zhengzhou 450000, China. Hauptthemen laut MEDLINE: Gefitinib, Epithelial-Mesenchymal Transition, Zinc Finger E-box-Binding Homeobox 1, Drug Resistance, Neoplasm. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academy of Medical Science, Zhengzhou University, Zhengzhou 450000, China.
- The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China.
Zitieren
APA
Zhou, F. M., Wang, K. K., Wang, L. H., Qiu, J. G., Wang, W., Liu, W. J., Wang, L., & Jiang, B. H. (2024). CIB2 mediates acquired gefitinib resistance by inducing ZEB1 expression and epithelial-mesenchymal transition. Aging. https://doi.org/10.18632/aging.206086
Vancouver
Zhou FM, Wang KK, Wang LH, Qiu JG, Wang W, Liu WJ, et al. CIB2 mediates acquired gefitinib resistance by inducing ZEB1 expression and epithelial-mesenchymal transition. Aging. 2024. doi:10.18632/aging.206086
BibTeX
@article{Zhou2024,
author = {Zhou, Feng-Mei and Wang, Kun-Kun and Wang, Li-Hong and Qiu, Jian-Ge and Wang, Wei and Liu, Wen-Jing and Wang, Lin and Jiang, Bing-Hua},
title = {CIB2 mediates acquired gefitinib resistance by inducing ZEB1 expression and epithelial-mesenchymal transition},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.206086}
}
EUVIMED